Rigel Pharmaceuticals | RIGL - Ebitda





Ebitda Değişiklik Tarih
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 3.86B 1.28B 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 5.16B 510M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Celldex Therapeutics USD -83.58M 2.76M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 10.29B 1.86B 2026-03
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Veracyte USD 43.96M 1.16M 2026-06